PODD · News · 20260804N

Securities Fraud Litigation

INSULET CORP · 2026-08-04 · Importance 40 · Surprise 42 · In source text

Multiple law firms reported a federal securities class action against Insulet and certain senior officers under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The allegations concern materially false or misleading statements about defective manufacturing controls, Omnipod safety, and two medical-device corrections during class periods beginning February 21, 2025, or May 21, 2025, and ending May 26, 2026. The action was filed in the U.S. District Court for the District of Massachusetts under docket 26-cv-13062. Investors have until August 31, 2026, to seek appointment as lead plaintiff.

Key facts

• A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet's Omnipod products. source
• The Gross Law Firm set a lead plaintiff deadline of August 31, 2026 for Insulet investors. source
• Numerous law firms reminded investors they have until August 31, 2026 to seek lead plaintiff status in the Insulet securities class action. source
• Multiple law firms (including Bernstein Liebhard, Faruqi & Faruqi, Pomerantz, Bronstein Gewirtz & Grossman, Levi & Korsinsky, SBS, DJS Law Group, The Gross Law Firm, SueWallSt, Rosen Law Firm) have issued shareholder alerts or filings related to securities class actions against Insulet citing purchases between February 21, 2025 and May 26, 2026 and an August 31, 2026 lead plaintiff deadline. source
• Shareholders who purchased PODD shares during the class period of February 21, 2025, to May 26, 2026, are encouraged to contact the firm. source
• Schall, Brown & Schwartz LLP reminded investors who purchased shares of PODD during the listed class period to contact the firm regarding possible lead plaintiff appointments for the securities class action. source

Impact estimates